In Depth
Also in this section
Power of collaboration more pertinent than ever says pharma experts
Newborn screening strategy needs modernising as HHS disbands advisory committee
Pharma’s AI prospects get nudged into the future with EU’s AI act
ATS 2025: Anti–IL-5 therapy cuts exacerbations in coexisting COPD and asthma patients
ATS 2025: Real-world data supports Trikafta as gold standard in long-term CF care